Decoy Therapeutics is focused on developing next-generation peptide conjugate therapeutics that leverage innovative approaches to enhance drug delivery and efficacy. Their technology platform is designed to optimize the therapeutic potential of peptides by conjugating them with various payloads, which can include small molecules or biologics. This strategy aims to improve the specificity and effectiveness of treatments while minimizing side effects, thereby addressing significant challenges in current therapeutic modalities.

The company’s pipeline includes a range of products that utilize these advanced peptide conjugate technologies, targeting various diseases and conditions. By harnessing the unique properties of peptides, Decoy Therapeutics aims to create therapeutics that can effectively penetrate tissues and cells, leading to improved therapeutic outcomes. Their commitment to scientific rigor and innovation positions them at the forefront of peptide-based therapeutic development, with the potential to transform treatment paradigms in multiple therapeutic areas.

United States

Decoy Therapeutics is a biotechnology company that engineers next-generation peptide conjugate therapies using AI/ML for rapid design and scalable manufacturing to protect and expand patient lives.

Decoy Therapeutics

Company Details